Concepedia

Maria Laura Sargentini‐Maier

ML

Statistics

Publications

14

Citations

867

H-Index

14

Active since

2007

Affiliations

UCB Pharma (Belgium)(Current)

Ablynx (Belgium)

Uppsala University

Maria Laura Sargentini‐Maier is an author at UCB Pharma (Belgium) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2007–2021

14

Publications

14

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

Maria Laura Sargentini‐Maier, Paul Rolan, John Connell et al. · British Journal of Clinical Pharmacology · 2007 · 137 citations · Full text

, , +13

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

Paul Rolan, Maria Laura Sargentini‐Maier, Etienne Pigeolet et al. · British Journal of Clinical Pharmacology · 2008 · 121 citations

, , +15

Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®

Sven Hoefman, Ingrid Ottevaere, Judith Baumeister et al. · Antibodies · 2015 · 118 citations · Full text

, , +13

Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects

Maria Laura Sargentini‐Maier, Pascal Espié, Alain Coquette et al. · Drug Metabolism and Disposition · 2007 · 115 citations

, , +13

Brivaracetam Disposition in Renal Impairment

Maria Laura Sargentini‐Maier, Antoni Sokalski, Pierre Boulanger et al. · The Journal of Clinical Pharmacology · 2012 · 60 citations

, , +16

1–5 of 14